{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:25:39Z","timestamp":1793805939476,"version":"4.6.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.urolonc.2026.06.008","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T20:49:02Z","timestamp":1784666942000},"page":"305-316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deep learning approaches for predicting response to neoadjuvant chemotherapy in muscle invasive bladder cancer: A systematic review"],"prefix":"10.1016","volume":"44","author":[{"given":"Mohammad Reza","family":"Nowroozi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hamidi","family":"Madani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirreza","family":"Farzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Mazdak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Niroomand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Hajiasadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra Tahamtani","family":"Torkamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laleh","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7982-9617","authenticated-orcid":false,"given":"Alireza","family":"Aminsharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2026.06.008_bib0001","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.13.04109","article-title":"The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040","volume":"13","author":"Zhang","year":"2023","journal-title":"J Glob Health"},{"issue":"3","key":"10.1016\/j.urolonc.2026.06.008_bib0002","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.eururo.2011.05.045","article-title":"Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review","volume":"60","author":"van den Bosch","year":"2011","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2026.06.008_bib0003","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/bju.12601","article-title":"Muscle-invasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base","volume":"114","author":"Smith","year":"2014","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.urolonc.2026.06.008_bib0004","doi-asserted-by":"crossref","first-page":"216","DOI":"10.6004\/jnccn.2024.0024","article-title":"NCCN Guidelines\u00ae insights: bladder cancer, Version 3.2024","volume":"22","author":"Flaig","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"issue":"11","key":"10.1016\/j.urolonc.2026.06.008_bib0005","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1001\/jamaoncol.2018.3542","article-title":"Downstaging and survival outcomes associated with neoadjuvant chemotherapy regimens among patients treated with cystectomy for muscle-invasive bladder cancer","volume":"4","author":"Peyton","year":"2018","journal-title":"JAMA Oncol"},{"issue":"9","key":"10.1016\/j.urolonc.2026.06.008_bib0006","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer","volume":"349","author":"Grossman","year":"2003","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.urolonc.2026.06.008_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111859","article-title":"Genomic heterogeneity as a barrier to precision oncology in urothelial cancer","volume":"41","author":"Clinton","year":"2022","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.urolonc.2026.06.008_bib0008","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1102\/1470-7330.2013.0015","article-title":"Quantifying tumour heterogeneity with CT","volume":"13","author":"Ganeshan","year":"2013","journal-title":"Cancer Imaging"},{"issue":"5","key":"10.1016\/j.urolonc.2026.06.008_bib0009","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.juro.2018.05.078","article-title":"Conservative management following complete clinical response to neoadjuvant chemotherapy of muscle invasive bladder cancer: contemporary outcomes of a multi-institutional cohort study","volume":"200","author":"Mazza","year":"2018","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.06.008_bib0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11934-025-01264-6","article-title":"Management of patients with muscle-invasive bladder cancer achieving a clinical complete response after neoadjuvant therapy: evidence and consideration for active surveillance","volume":"26","author":"Joffe","year":"2025","journal-title":"Curr Urol Rep"},{"issue":"3","key":"10.1016\/j.urolonc.2026.06.008_bib0011","first-page":"E113","article-title":"Development of a radiomic signature for predicting response to neoadjuvant chemotherapy in muscle-invasive bladder cancer","volume":"16","author":"Parmar","year":"2022","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.urolonc.2026.06.008_bib0012","series-title":"Deep cognitive modelling in remote sensing image processing","first-page":"113","article-title":"Advancements in machine learning and deep learning","author":"Darwish","year":"2024"},{"key":"10.1016\/j.urolonc.2026.06.008_bib0013","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neucom.2020.04.157","article-title":"Convolutional neural networks for medical image analysis: state-of-the-art, comparisons, improvement and perspectives","volume":"444","author":"Yu","year":"2021","journal-title":"Neurocomputing"},{"key":"10.1016\/j.urolonc.2026.06.008_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.108635","article-title":"A review of deep learning-based information fusion techniques for multimodal medical image classification","volume":"177","author":"Li","year":"2024","journal-title":"Comput Biol Med"},{"issue":"1","key":"10.1016\/j.urolonc.2026.06.008_bib0020","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7326\/M18-1376","article-title":"PROBAST: a tool to assess the risk of bias and applicability of prediction model studies","volume":"170","author":"Wolff","year":"2019","journal-title":"Ann Intern Med"},{"issue":"13","key":"10.1016\/j.urolonc.2026.06.008_bib0022","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.3390\/cancers16132402","article-title":"Outcome prediction using multi-modal information: integrating large language model-extracted clinical information and image analysis","volume":"16","author":"Sun","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.urolonc.2026.06.008_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102352","article-title":"Deep learning signature based on multiphase enhanced CT for bladder cancer recurrence prediction: a multi-center study","volume":"66","author":"Wang","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"2","key":"10.1016\/j.urolonc.2026.06.008_bib0028","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3390\/tomography8020054","article-title":"Computerized decision support for bladder cancer treatment response assessment in CT urography: effect on diagnostic accuracy in multi-institution multi-specialty study","volume":"8","author":"Sun","year":"2022","journal-title":"Tomography"},{"issue":"1","key":"10.1016\/j.urolonc.2026.06.008_bib0031","doi-asserted-by":"crossref","first-page":"8738","DOI":"10.1038\/s41598-017-09315-w","article-title":"Bladder cancer treatment response assessment in CT using radiomics with deep-learning","volume":"7","author":"Cha","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.urolonc.2026.06.008_bib0021","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3390\/app14020669","article-title":"MVMSGAT: integrating multiview, multi-scale graph convolutional networks with biological prior knowledge for predicting bladder cancer response to neoadjuvant therapy","volume":"14","author":"Luo","year":"2024","journal-title":"Appl Sci Basel"},{"issue":"9","key":"10.1016\/j.urolonc.2026.06.008_bib0024","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.acra.2018.10.010","article-title":"Diagnostic accuracy of CT for prediction of bladder cancer treatment response with and without computerized decision support","volume":"26","author":"Cha","year":"2019","journal-title":"Acad Radiol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.06.008_bib0029","doi-asserted-by":"crossref","first-page":"8738","DOI":"10.1038\/s41598-017-09315-w","article-title":"Bladder cancer treatment response assessment in CT using radiomics with deep-learning","volume":"7","author":"Cha","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.urolonc.2026.06.008_bib0030","article-title":"Bladder cancer treatment response assessment in CT urography using two-channel deep-learning network","volume":"10575","author":"Cha","year":"2018","journal-title":"Proc SPIE Med Imaging"},{"issue":"4","key":"10.1016\/j.urolonc.2026.06.008_bib0032","doi-asserted-by":"crossref","first-page":"421","DOI":"10.18383\/j.tom.2016.00184","article-title":"Bladder cancer segmentation in CT for treatment response assessment: application of deep-learning convolution neural network-a pilot study","volume":"2","author":"Cha","year":"2016","journal-title":"Tomography"},{"issue":"1","key":"10.1016\/j.urolonc.2026.06.008_bib0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.18383\/j.tom.2018.00036","article-title":"Deep learning approach for assessment of bladder cancer treatment response","volume":"5","author":"Wu","year":"2019","journal-title":"Tomography"},{"key":"10.1016\/j.urolonc.2026.06.008_bib0026","article-title":"Multi-institutional observer performance study for bladder cancer treatment response assessment in CT urography with and without computerized decision support","volume":"11597","author":"Hadjiiski","year":"2021","journal-title":"Proc SPIE Med Imaging"},{"issue":"2","key":"10.1016\/j.urolonc.2026.06.008_bib0027","doi-asserted-by":"crossref","first-page":"194","DOI":"10.18383\/j.tom.2020.00013","article-title":"Intraobserver variability in bladder cancer treatment response assessment with and without computerized decision support","volume":"6","author":"Hadjiiski","year":"2020","journal-title":"Tomography"},{"issue":"1","key":"10.1016\/j.urolonc.2026.06.008_bib0015","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41698-024-00731-6","article-title":"Integrated multicenter deep learning system for prognostic prediction in bladder cancer","volume":"8","author":"He","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.urolonc.2026.06.008_bib0016","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.urolonc.2026.06.008_bib0017","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.eururo.2023.08.016","article-title":"European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2023 guidelines","volume":"85","author":"Alfred Witjes","year":"2024","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.06.008_bib0018","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"issue":"9","key":"10.1016\/j.urolonc.2026.06.008_bib0019","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.35377","article-title":"APPRAISE-ai tool for quantitative evaluation of AI studies for clinical decision support","volume":"6","author":"Kwong","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.urolonc.2026.06.008_bib0033","doi-asserted-by":"crossref","first-page":"E276","DOI":"10.5489\/cuaj.8681","article-title":"Artificial intelligence for predicting response to neoadjuvant chemotherapy for bladder cancer A comprehensive systematic review and meta-analysis","volume":"18","author":"Suartz","year":"2024","journal-title":"Can Urol Assoc J"},{"issue":"3","key":"10.1016\/j.urolonc.2026.06.008_bib0034","doi-asserted-by":"crossref","DOI":"10.1148\/ryai.210064","article-title":"External validation of deep learning algorithms for radiologic diagnosis: a systematic review","volume":"4","author":"Yu","year":"2022","journal-title":"Radiol Artif Intell"},{"key":"10.1016\/j.urolonc.2026.06.008_bib0035","article-title":"Heterogeneity in precision oncology","volume":"2","author":"Tomasik","year":"2023","journal-title":"Camb Prism Precis Med"},{"key":"10.1016\/j.urolonc.2026.06.008_bib0040","article-title":"Development of a MRI-based radiomics nomogram for prediction of response of patients with muscle-invasive bladder cancer to neoadjuvant chemotherapy","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.urolonc.2026.06.008_bib0041","first-page":"1","article-title":"Integrating artificial intelligence across the bladder cancer continuum: progress, promise, and pitfalls","author":"Saran Manivasagam","year":"2025","journal-title":"Expert Rev Anticancer Ther"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926005673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926005673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T14:27:32Z","timestamp":1793802452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143926005673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1078143926005673"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.06.008","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deep learning approaches for predicting response to neoadjuvant chemotherapy in muscle invasive bladder cancer: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}